Pacira BioSciences, Inc. (PCRX)
NASDAQ · Manufacturing · Pharmaceutical preparations
PCRX price, last 12 months
Key stats
- Previous close
- $25.56
- Open
- $25.49
- Day range
- $25.00 – $25.67
- 52-week range
- $18.80 – $27.66
- Volume
- 341.6K
- Avg volume (20 days)
- 543.2K
- Market cap
- $1.0B
Performance
Technicals and fundamentals
About Pacira BioSciences, Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $1.0B